Abbott, AbbVie Hit With $2.2M Verdict In Humira Suit

By Greg Ryan (May 9, 2013, 7:28 PM EDT) -- A Chicago jury slapped Abbott Laboratories and AbbVie Inc. with a $2.2 million verdict Thursday in a suit brought by a man whose wife allegedly suffered a life-threatening fungal infection as a result of taking the blockbuster arthritis drug Humira.

The state court jury found for plaintiff Milton Tietz on his negligence claim, though it found for the companies on a product defect claim, according to Jim Perdue Jr. of Perdue Kidd & Vickery, an attorney for Tietz. Abbott spun off AbbVie earlier this year.

Counsel for Tietz have said the case is the first such Humira product liability suit to...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!